We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

103 hedge funds and large institutions have $456M invested in Foundation Medicine, Inc. in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more call options, than puts

Call options by funds: $40.2M | Put options by funds: $15.5M

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

54% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 24

26% more capital invested

Capital invested by funds: $362M → $456M (+$94.2M)

11% more funds holding

Funds holding: 93103 (+10)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
103
Holders Change
+10
Holders Change %
+10.75%
% of All Funds
2.57%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
19
Increased
37
Reduced
24
Closed
9
Calls
$40.2M
Puts
$15.5M
Net Calls
+$24.8M
Net Calls Change
+$23M
Name Holding Trade Value Shares
Change
Change in
Stake
KCM
51
Karp Capital Management
California
$497K +$458K +12,500 New
DM
52
Diker Management
New York
$477K
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$467K +$12.5K +341 +3%
Wells Fargo
54
Wells Fargo
California
$458K +$34.1K +931 +9%
CA
55
Commerzbank Aktiengesellschaft
Germany
$437K -$13.2K -360 -3%
State of Wisconsin Investment Board
56
State of Wisconsin Investment Board
Wisconsin
$437K +$403K +11,000 New
IA
57
IFP Advisors
Florida
$425K -$80.7K -2,205 -17%
AQR Capital Management
58
AQR Capital Management
Connecticut
$421K +$388K +10,590 New
SCM
59
Sterling Capital Management
North Carolina
$419K
CL
60
CSS LLC
Illinois
$417K -$62.2K -1,700 -14%
MLICM
61
Metropolitan Life Insurance Company (MetLife)
New York
$417K +$8.09K +221 +2%
ONB
62
Old National Bancorp
Indiana
$398K
RFS
63
Rockefeller Financial Services
New York
$398K
AIG
64
American International Group
New York
$353K +$22K +600 +7%
Citadel Advisors
65
Citadel Advisors
Florida
$338K +$311K +8,507 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$332K +$58K +1,585 +23%
NFA
67
Nationwide Fund Advisors
Ohio
$310K
VOYA Investment Management
68
VOYA Investment Management
Georgia
$262K +$242K +6,598 New
Bank of America
69
Bank of America
North Carolina
$248K +$2.53K +69 +1%
ACI
70
AMP Capital Investors
Australia
$244K +$220K +6,020 New
Creative Planning
71
Creative Planning
Kansas
$202K +$24.7K +675 +15%
SG Americas Securities
72
SG Americas Securities
New York
$189K -$15.5K -424 -8%
WAM
73
Wealthspire Advisors (Maryland)
Maryland
$159K
Legal & General Group
74
Legal & General Group
United Kingdom
$138K +$10K +274 +9%
Russell Investments Group
75
Russell Investments Group
United Kingdom
$123K -$1.24M -33,962 -92%

FMI Hedge Fund Activity: Q2 2017 in Review

103 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q2 2017, worth a combined $456M — up 26% from $362M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FMI positions and 9 closed out — a net gain of 10 holders — while 37 added to existing stakes and 24 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $12.6M. The largest seller was Discovery Group I, cutting an estimated $17.4M.

  • 103 institutional investors held Foundation Medicine, Inc. (FMI) as of Q2 2017, up from 93 in Q1 2017.
  • Funds reported $456M of Foundation Medicine, Inc. stock for Q2 2017, up 26% quarter-over-quarter.
  • 19 funds opened new Foundation Medicine, Inc. positions in Q2 2017 and 9 closed out, a net change of +10 holders.
  • The largest Foundation Medicine, Inc. buyer in Q2 2017 was Lord, Abbett & Co, an estimated $12.6M added.
  • The largest Foundation Medicine, Inc. seller in Q2 2017 was Discovery Group I, an estimated $17.4M sold.

Based on aggregated 13F filings for Q2 2017.